Metabolic risk in PCOS

Phenotype and adiposity impact

Lisa J. Moran, Robert J. Norman, Helena J. Teede

Research output: Contribution to journalReview ArticleOtherpeer-review

Abstract

Polycystic ovary syndrome (PCOS) is a common condition in reproductive-aged women, with reproductive, cardiometabolic, and psychological features. The heterogeneity in insulin resistance, obesity, and cardiometabolic features has led to controversy on the independent contributions of PCOS status, diagnostic criteria, phenotype, and adiposity. It now appears that women with PCOS have an increased risk of insulin resistance and cardiometabolic features, which is independent of, but worsened by, adiposity and central adiposity, and is unrelated to reproductive phenotype. Obesity may be more prevalent in the more severe phenotypes, which suggests either an exacerbation of the reproductive features or a more likely diagnosis in overweight women with PCOS. Therefore, all women with PCOS should be targeted for prevention, screening, and management of cardiometabolic features.

Original languageEnglish
Pages (from-to)136-143
Number of pages8
JournalTrends in Endocrinology and Metabolism
Volume26
Issue number3
DOIs
Publication statusPublished - 1 Mar 2015

Keywords

  • Cardiometabolic
  • Diagnostic criteria
  • Insulin resistance
  • Obesity
  • Polycystic ovary syndrome

Cite this

@article{c7c4b8d803854f3097ea45bdba0222e3,
title = "Metabolic risk in PCOS: Phenotype and adiposity impact",
abstract = "Polycystic ovary syndrome (PCOS) is a common condition in reproductive-aged women, with reproductive, cardiometabolic, and psychological features. The heterogeneity in insulin resistance, obesity, and cardiometabolic features has led to controversy on the independent contributions of PCOS status, diagnostic criteria, phenotype, and adiposity. It now appears that women with PCOS have an increased risk of insulin resistance and cardiometabolic features, which is independent of, but worsened by, adiposity and central adiposity, and is unrelated to reproductive phenotype. Obesity may be more prevalent in the more severe phenotypes, which suggests either an exacerbation of the reproductive features or a more likely diagnosis in overweight women with PCOS. Therefore, all women with PCOS should be targeted for prevention, screening, and management of cardiometabolic features.",
keywords = "Cardiometabolic, Diagnostic criteria, Insulin resistance, Obesity, Polycystic ovary syndrome",
author = "Moran, {Lisa J.} and Norman, {Robert J.} and Teede, {Helena J.}",
year = "2015",
month = "3",
day = "1",
doi = "10.1016/j.tem.2014.12.003",
language = "English",
volume = "26",
pages = "136--143",
journal = "Trends in Endocrinology and Metabolism",
issn = "1043-2760",
publisher = "Elsevier",
number = "3",

}

Metabolic risk in PCOS : Phenotype and adiposity impact. / Moran, Lisa J.; Norman, Robert J.; Teede, Helena J.

In: Trends in Endocrinology and Metabolism, Vol. 26, No. 3, 01.03.2015, p. 136-143.

Research output: Contribution to journalReview ArticleOtherpeer-review

TY - JOUR

T1 - Metabolic risk in PCOS

T2 - Phenotype and adiposity impact

AU - Moran, Lisa J.

AU - Norman, Robert J.

AU - Teede, Helena J.

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Polycystic ovary syndrome (PCOS) is a common condition in reproductive-aged women, with reproductive, cardiometabolic, and psychological features. The heterogeneity in insulin resistance, obesity, and cardiometabolic features has led to controversy on the independent contributions of PCOS status, diagnostic criteria, phenotype, and adiposity. It now appears that women with PCOS have an increased risk of insulin resistance and cardiometabolic features, which is independent of, but worsened by, adiposity and central adiposity, and is unrelated to reproductive phenotype. Obesity may be more prevalent in the more severe phenotypes, which suggests either an exacerbation of the reproductive features or a more likely diagnosis in overweight women with PCOS. Therefore, all women with PCOS should be targeted for prevention, screening, and management of cardiometabolic features.

AB - Polycystic ovary syndrome (PCOS) is a common condition in reproductive-aged women, with reproductive, cardiometabolic, and psychological features. The heterogeneity in insulin resistance, obesity, and cardiometabolic features has led to controversy on the independent contributions of PCOS status, diagnostic criteria, phenotype, and adiposity. It now appears that women with PCOS have an increased risk of insulin resistance and cardiometabolic features, which is independent of, but worsened by, adiposity and central adiposity, and is unrelated to reproductive phenotype. Obesity may be more prevalent in the more severe phenotypes, which suggests either an exacerbation of the reproductive features or a more likely diagnosis in overweight women with PCOS. Therefore, all women with PCOS should be targeted for prevention, screening, and management of cardiometabolic features.

KW - Cardiometabolic

KW - Diagnostic criteria

KW - Insulin resistance

KW - Obesity

KW - Polycystic ovary syndrome

UR - http://www.scopus.com/inward/record.url?scp=84923570421&partnerID=8YFLogxK

U2 - 10.1016/j.tem.2014.12.003

DO - 10.1016/j.tem.2014.12.003

M3 - Review Article

VL - 26

SP - 136

EP - 143

JO - Trends in Endocrinology and Metabolism

JF - Trends in Endocrinology and Metabolism

SN - 1043-2760

IS - 3

ER -